DEC 08, 2020 12:28 PM PST

Stress hormones interrupt tumor cells' hibernation

A new study published in Science Translational Medicine suggests that the hormones released from stress could “reawaken” dormant cancer cells from their hibernation. The finding provides insight on one mechanism that contributes to why cancer returns after patients are in recession.

Why cancers return is a question that plagues both physicians and patients alike. The recurrence of tumors is considered one of the most significant causes of death in cancer patients, though scientists still don’t fully understand the mechanisms that trigger a recurrence.

The study was conducted in mice models and used data from 80 patients with lung cancer. Led by Michela Perego and colleagues, the team of researchers looked at how mice in stressful situations release increased levels of stress hormones like norepinephrine. This in turn triggers immune cells called neutrophils to release S100A8/A9 proteins and fatty molecules that ultimately resulted in lung and ovarian tumor cells to emerge from their long sleep.

This discovery opens up a new pathway for drug development and extended cancer treatment. If a drug can target and inhibit certain stress hormones, it may be able to keep tumor cells in a dormant state.

Beta-blockers are a class of drugs known for their properties of targeting stress hormones. To try out this idea, the researchers gave stressed mice an experimental beta-blocker and showed that their tumor cells stayed dormant. They observed similar results in humans with lung cancer, showing that patients with higher concentrations of S100A8/A9 were more likely to have experienced recurrence 33 months after surgery.

Photo: Pexels

Perego’s team says that their research provides evidence that beta-blockers or similar drugs that target S100A8/A9 proteins should be analyzed to see if they could serve as potential therapies to prevent a recurrence.  

Sources: Science Translational Medicine, Eureka Alert

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
JUN 08, 2021
Immunology
Fueling the Immune System's Killers
JUN 08, 2021
Fueling the Immune System's Killers
There’s a group of “killers” protecting your body against infections and eliminating potentially cance ...
JUN 09, 2021
Clinical & Molecular DX
Faster, Cheaper Diagnosis of Rare Cancer in Fat Cells
JUN 09, 2021
Faster, Cheaper Diagnosis of Rare Cancer in Fat Cells
Scientists have created a gene panel test to quickly and more precisely diagnose common forms of liposarcoma. This break ...
JUN 04, 2021
Cancer
Cancer patients with COVID-19 fare better with remote health monitoring
JUN 04, 2021
Cancer patients with COVID-19 fare better with remote health monitoring
A new study presented last week at the American Society of Clinical Oncology Annual Meeting after its publication in the ...
JUN 09, 2021
Technology
Computer Program Generates Effective, Clinically-valid Treatment Plans for Cancer Patients
JUN 09, 2021
Computer Program Generates Effective, Clinically-valid Treatment Plans for Cancer Patients
In a recent study published in Nature Medicine, researchers at the Princess Margaret Cancer Centre offer evidence for th ...
AUG 04, 2021
Health & Medicine
Cannabis Drug Sativex to Be Tested in Phase II Brain Tumor Trial
AUG 04, 2021
Cannabis Drug Sativex to Be Tested in Phase II Brain Tumor Trial
  A phase II trial is being planned to test the cannabis-derived drug Sativex, in patients with aggressive brain tu ...
AUG 23, 2021
Cancer
A Safe and Effective Combination Therapy for Advanced Cancer
AUG 23, 2021
A Safe and Effective Combination Therapy for Advanced Cancer
Immunotherapies are emerging as a promising strategy for the treatment of late-stage cancers which currently have m ...
Loading Comments...